Intended Level of Study
5 years of post-secondary education
Training Structure
School of Pharmacy
Language(s) of Instruction
French
Overview
Applied Pharmacology in Oncology: From the Development of Anticancer Drugs to Patient Care.
Pharmacology in oncology is constantly evolving, making it possible to offer an ever-increasing number of therapeutic innovations to oncologists and, above all, to patients undergoing treatment. For several years now, the cancer care pathway has been transformed by the rise of oral therapies. Dispensed at the pharmacy and taken at home by the patient, these oral therapies—which carry numerous side effects—require optimal support to ensure not only efficacy but, above all, safety.
This University Diploma in Oncology Pharmacology addresses the high demand from professionals in the field (continuing education) and soon-to-be graduates (initial training) who are seeking instruction that is both technical and practical to ensure safe cancer care pathways.
To acquire knowledge of clinical oncology and pharmacology (from biology to treatments) and apply it to patient care. This university diploma program offers a core curriculum required for all participants, followed by a choice of two tracks: Track 1—Community Pharmacy and Track 2—Hospital Pharmacy.
The Benefits of the Training Program
As part of Track 1 (Pharmacy), this university certificate program provides you with the training needed to assist patients and distribute colorectal cancer screening kits to them, in collaboration with the CRCDC Occitanie.
Objectives
- Conduct pharmaceutical consultations to provide personalized information and advice to patients taking anticancer medications.
- Support the patient in managing the side effects of treatment.
- Analyze the treatment strategy to optimize the patient's care pathway.
- Assist the oncologist in tailoring the patient's care plan.
- Support the patient and the healthcare team in managing the side effects of treatment.
Program
- 1 academic year.
- In-person classes, in the form of a monthly 2-day module (Monday and Tuesday) led by professionals in the field (oncologist, pharmacologist, hospital pharmacist, community pharmacist, patient advocate, advanced practice nurse, etc.).The program is tailored to participants’ needs, featuring a core curriculum in oncology pharmacology and an elective (either hospital-based or community pharmacy-based, at the participant’s discretion). Held on the Faculty of Pharmacy campus.
PROGRAM
CORE CURRICULUM (65 hours)
The Biology of Cancer: From Carcinogenesis to Cancer Biomarkers
Pharmacokinetics of Anticancer Drugs: Pharmacokinetics and the PK/PD Relationship. Drug Interactions (Conventional Medicine and Complementary Therapies)
Toxicity of Cancer Treatments: Drug-Induced Toxicity in Oncology. Skin Toxicity. Cardiotoxicity. Immunotoxicity.
Cancer Drugs: Chemotherapy, Hormone Therapy, Targeted Therapy, Immunotherapy, Combination Therapies: ADC, TO+IV, Innovative Drugs and Biotherapies, Radiopharmaceuticals.
Types of Cancer and Their Management: Breast Cancer, Gastrointestinal Cancers, Lung Cancer, Skin Cancer, Prostate Cancer, Medical Oncology and Hematology, Oncology Emergencies.
The Drug Development Process: From Research to Dispensing:
- Clinical research, drug distribution (reimbursements, early access, etc.)
- Care pathway: patient support and coordination between community and hospital settings (Pharmacist and Pharmacy Technician)
- Geriatric Oncology
- Pharmacovigilance in Oncology
- Patient Partnership: From Clinical Research to Support
- Supportive Care: Overview, Clinical Case, and Focus on Nutrition
PATH 1 - RETAIL PHARMACY
- The patient's journey from the hospital to the community:
- Personalized care plan, care procedures, follow-up procedures, support, etc.
- Managing Side Effects in the Pharmacy: Tools and Guides
- Pharmaceutical Counseling at the Pharmacy: From Theory to Practice
Training conducted in partnership with community pharmacists and patient partners (10 hours)
PATH 2 - HOSPITAL and INDUSTRY
- Isotechnology and production area, automation, standard dose, Good Manufacturing Practices
- Pharmacological Treatment Monitoring
- Pharmacogenetics of Anticancer Drugs
- New Methods of Administering Anticancer Drugs (PIPAC, Chemoembolization, SC)
Admission
Admission Requirements
Applications:
Send your resume and cover letter to pharma-du @ umontpellier.fr between September 15 and November 15—without fail.
Incomplete applications or those submitted after the deadline will not be processed.
Target Audience
PATH 1: RETAIL PHARMACY
Initial Training
- Pharmacy students starting in their 6th year (DFASP2 completed).
Continuing Education
- Licensed community pharmacists and other community pharmacy professionals (minimum 4 years of post-secondary education) based on a review of their application.
PATH 2: HOSPITAL AND INDUSTRY
Initial Training
- Pharmacy students in their 6th year or higher (who have successfully completed DFASP2) and pharmacy residents and medical residents.
Continuing Education
- Hospital or pharmaceutical industry pharmacist, general practitioner or specialist, other healthcare professionals (including employees of the pharmaceutical industry), pharmacy technician, patient partner, or expert
And then
Continuing Your Education Abroad
No.